Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
Gliomas are the most common primary central nervous system malignancy and have an overall poor prognosis, despite aggressive treatment. Understanding the immune microenvironment of these fatal tumors will advance discovery of immune-related therapeutic targets. Natural killer (NK) cells are innate l...
Main Authors: | Xiaoran Zhang, Aleksandra Safonova, Aparna Rao, Nduka Amankulor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Glioma |
Subjects: | |
Online Access: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=3;spage=133;epage=138;aulast=Zhang |
Similar Items
-
Biochemical Characterization and Genetic Modeling of Glioma-Associated Mutations in Isocitrate Dehydrogenases.
by: Lopez, Giselle Yvette
Published: (2014) -
Histologic characterization of the immune infiltrate in isocitrate dehydrogenase wild-type and mutant World Health Organization Grade II and III gliomas
by: Josine A. E. M. Jansen, et al.
Published: (2018-01-01) -
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
by: Danielle Golub, et al.
Published: (2019-05-01) -
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
by: Juan Huang, et al.
Published: (2019-06-01) -
Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01)